285 Stimulated Raman scattering microscopy provides a rapid, label-free means of detecting tumor infiltration of brain tissue ex vivo and in vivo.
http://stm.sciencemag.org/content/5/201/201ra119.abstract
284 Neovascular structures in acute myeloid leukemia can be targeted using a cognate antibody fused to human interleukin-2.
http://stm.sciencemag.org/content/5/201/201ra118.abstract
283 Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors.
http://www.pnas.org/content/110/36/14711.abstract
282 NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth.
http://www.pnas.org/content/110/36/14676.abstract
281 Engineered knottin peptide enables noninvasive optical imaging of intracranial medulloblastoma.
http://www.pnas.org/content/110/36/14598.abstract
280 Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy.
http://www.pnas.org/content/110/36/E3445.abstract
279 Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells.
http://stm.sciencemag.org/content/5/200/200ra116.abstract
278 Bombarding Cancer: Biolistic Delivery of therapeutics using Porous Si Carriers.
http://www.nature.com/srep/2013/130826/srep02499/full/srep02499.html
277 Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.
http://www.pnas.org/content/110/35/E3281
276 Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma.
http://jem.rupress.org/content/210/9/1695.abstract
275 Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer.
http://www.cell.com/cancer-cell/abstract/S1535-6108(13)00288-2
274 An analysis of mutations from over 7,000 cancers of diverse origins reveals the diversity of mutational processes underlying the development of cancer.
http://www.nature.com/nature/journal/v500/n7463/full/nature12477.html
273 Hydrophobic Anticancer Drug Delivery by a 980 nm Laser-Driven Photothermal Vehicle for Efficient Synergistic Therapy of Cancer Cells In Vivo.
http://onlinelibrary.wiley.com/doi/10.1002/adma.201301232/abstract
272 Fluorescent Multiblock π-Conjugated Polymer Nanoparticles for In Vivo Tumor Targeting.
http://onlinelibrary.wiley.com/doi/10.1002/adma.201301656/abstract
271 Immunization of fucose-containing polysaccharides from Reishi mushroom induces antibodies to tumor-associated Globo H-series epitopes.
http://www.pnas.org/content/110/34/13809.abstract
270 Hybrid Melittin Cytolytic Peptide-Driven Ultrasmall Lipid Nanoparticles Block Melanoma Growth in Vivo.
http://pubs.acs.org/doi/abs/10.1021/nn400683s
269 Computational Modeling of ERBB2-Amplified Breast Cancer Identifies Combined ErbB2/3 Blockade as Superior to the Combination of MEK and AKT Inhibitors.
http://stke.sciencemag.org/cgi/content/abstract/sigtrans;6/288/ra68
268 Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation.
http://www.pnas.org/content/110/33/13576.abstract
267 Par-4 Downregulation Promotes Breast Cancer Recurrence by Preventing Multinucleation following Targeted Therapy.
http://www.cell.com/cancer-cell/abstract/S1535-6108(13)00234-1
266 Directed Phenotype Switching as an Effective Antimelanoma Strategy.
http://www.cell.com/cancer-cell/abstract/S1535-6108(13)00236-5
|
